_id
691b0e353c536f8df2318a10
Ticker
ALINT.PA
Name
Integragen
Exchange
PA
Address
Genopole Campus 1 BAt. 8, Évry, France, 91000
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://integragen.com
Description
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was incorporated in 2000 and is headquartered in Évry, France. IntegraGen SA operates as a subsidiary of OncoDNA SA.
Last Close
0.136
Volume
1591
Current Price
0.1365
Change
1.4705882352941189
Last Updated
2025-12-30T12:38:25.413Z
Image
https://logo.clearbit.com/integragen.com
Ipo Date
-
Market Cap
900416
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
2564098
Cost Of Revenue
4025250
Gross Profit
-1461152
Operating Expenses
46186
Operating Income
-1507335
Interest Expense
1494
Pretax Income
-1445836
Net Income
-1407106
Eps
-0.21297857539418502
Dividends Per Share
-
Shares Outstanding
6606796
Income Tax Expense
-38730
EBITDA
-1418970
Operating Margin
-58.78616963938196
Total Other Income Expense Net
61499
Cash
1679114
Short Term Investments
41654
Receivables
1171336
Inventories
269191
Total Current Assets
3386805
Property Plant Equipment
87866
Total Assets
3602250
Payables
942428
Short Term Debt
-
Long Term Debt
-
Total Liabilities
3264212
Equity
338035
Bs_currency_symbol
-
Depreciation
25369
Change In Working Capital
752350
Cash From Operations
-645507
Capital Expenditures
723
Cash From Investing
3706
Cash From Financing
462176
Net Change In Cash
825624
Cf_currency_symbol
-
PE
-
PB
2.6678528968893755
ROE
-416.2604464034789
ROA
-39.06186411270733
FCF
-646230
Fcf Percent
-0.2520301486136645
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
3.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
4
Quality Investing Score
1.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2564098
Quarters > 0 > income Statement > cost Of Revenue
4025250
Quarters > 0 > income Statement > gross Profit
-1461152
Quarters > 0 > income Statement > operating Expenses
46186
Quarters > 0 > income Statement > operating Income
-1507335
Quarters > 0 > income Statement > interest Expense
1494
Quarters > 0 > income Statement > pretax Income
-1445836
Quarters > 0 > income Statement > net Income
-1407106
Quarters > 0 > income Statement > eps
-0.21297857539418502
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
6606796
Quarters > 0 > income Statement > income Tax Expense
-38730
Quarters > 0 > income Statement > EBITDA
-1418970
Quarters > 0 > income Statement > operating Margin
-58.78616963938196
Quarters > 0 > income Statement > total Other Income Expense Net
61499
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1679114
Quarters > 0 > balance Sheet > short Term Investments
41654
Quarters > 0 > balance Sheet > receivables
1171336
Quarters > 0 > balance Sheet > inventories
269191
Quarters > 0 > balance Sheet > total Current Assets
3386805
Quarters > 0 > balance Sheet > property Plant Equipment
87866
Quarters > 0 > balance Sheet > total Assets
3602250
Quarters > 0 > balance Sheet > payables
942428
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3264212
Quarters > 0 > balance Sheet > equity
338035
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-1407106
Quarters > 0 > cash Flow > depreciation
25369
Quarters > 0 > cash Flow > change In Working Capital
752350
Quarters > 0 > cash Flow > cash From Operations
-645507
Quarters > 0 > cash Flow > capital Expenditures
723
Quarters > 0 > cash Flow > cash From Investing
3706
Quarters > 0 > cash Flow > cash From Financing
462176
Quarters > 0 > cash Flow > net Change In Cash
825624
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.21297857539418502
Quarters > 0 > ratios > PB
2.6678528968893755
Quarters > 0 > ratios > ROE
-416.2604464034789
Quarters > 0 > ratios > ROA
-39.06186411270733
Quarters > 0 > ratios > FCF
-646230
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.2520301486136645
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
4101098
Quarters > 1 > income Statement > cost Of Revenue
1860605
Quarters > 1 > income Statement > gross Profit
2267395
Quarters > 1 > income Statement > operating Expenses
597948
Quarters > 1 > income Statement > operating Income
-397000
Quarters > 1 > income Statement > interest Expense
2150
Quarters > 1 > income Statement > pretax Income
-200854
Quarters > 1 > income Statement > net Income
-140384
Quarters > 1 > income Statement > eps
-0.020899999374715084
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6716938
Quarters > 1 > income Statement > income Tax Expense
-60470
Quarters > 1 > income Statement > EBITDA
-1787070
Quarters > 1 > income Statement > operating Margin
-9.68033438849791
Quarters > 1 > income Statement > total Other Income Expense Net
196148
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1900000
Quarters > 1 > balance Sheet > short Term Investments
1046990
Quarters > 1 > balance Sheet > receivables
3156000
Quarters > 1 > balance Sheet > inventories
205000
Quarters > 1 > balance Sheet > total Current Assets
5262000
Quarters > 1 > balance Sheet > property Plant Equipment
112788
Quarters > 1 > balance Sheet > total Assets
5515000
Quarters > 1 > balance Sheet > payables
912942
Quarters > 1 > balance Sheet > short Term Debt
453403
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3759000
Quarters > 1 > balance Sheet > equity
1755000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-140384
Quarters > 1 > cash Flow > depreciation
-706590
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.020899999374715084
Quarters > 1 > ratios > PB
0.5224285111111112
Quarters > 1 > ratios > ROE
-7.99908831908832
Quarters > 1 > ratios > ROA
-2.545494106980961
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
4570000
Quarters > 2 > income Statement > cost Of Revenue
5051395
Quarters > 2 > income Statement > gross Profit
-481395
Quarters > 2 > income Statement > operating Expenses
2052052
Quarters > 2 > income Statement > operating Income
-409998
Quarters > 2 > income Statement > interest Expense
2708
Quarters > 2 > income Statement > pretax Income
-151000
Quarters > 2 > income Statement > net Income
-115000
Quarters > 2 > income Statement > eps
-0.017100000505565233
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6725146
Quarters > 2 > income Statement > income Tax Expense
-36000
Quarters > 2 > income Statement > EBITDA
-119503
Quarters > 2 > income Statement > operating Margin
-8.971509846827134
Quarters > 2 > income Statement > total Other Income Expense Net
128907
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
861788
Quarters > 2 > balance Sheet > short Term Investments
1045603
Quarters > 2 > balance Sheet > receivables
3480391
Quarters > 2 > balance Sheet > inventories
334000
Quarters > 2 > balance Sheet > total Current Assets
5970000
Quarters > 2 > balance Sheet > property Plant Equipment
114447
Quarters > 2 > balance Sheet > total Assets
6217000
Quarters > 2 > balance Sheet > payables
935507
Quarters > 2 > balance Sheet > short Term Debt
452828
Quarters > 2 > balance Sheet > long Term Debt
416195
Quarters > 2 > balance Sheet > total Liabilities
4322000
Quarters > 2 > balance Sheet > equity
1891694
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-115616
Quarters > 2 > cash Flow > depreciation
28938
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.017100000505565233
Quarters > 2 > ratios > PB
0.4852700431465132
Quarters > 2 > ratios > ROE
-6.079207313656437
Quarters > 2 > ratios > ROA
-1.84976676853788
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
6483907
Quarters > 3 > income Statement > cost Of Revenue
3786804
Quarters > 3 > income Statement > gross Profit
2697103
Quarters > 3 > income Statement > operating Expenses
2423328
Quarters > 3 > income Statement > operating Income
273775
Quarters > 3 > income Statement > interest Expense
3875
Quarters > 3 > income Statement > pretax Income
90563
Quarters > 3 > income Statement > net Income
90901
Quarters > 3 > income Statement > eps
0.013797670693447514
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
6588141
Quarters > 3 > income Statement > income Tax Expense
-338
Quarters > 3 > income Statement > EBITDA
167332
Quarters > 3 > income Statement > operating Margin
4.2223770328599715
Quarters > 3 > income Statement > total Other Income Expense Net
-183212
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1834484
Quarters > 3 > balance Sheet > short Term Investments
1044179
Quarters > 3 > balance Sheet > receivables
4302564
Quarters > 3 > balance Sheet > inventories
311449
Quarters > 3 > balance Sheet > total Current Assets
7684292
Quarters > 3 > balance Sheet > property Plant Equipment
143386
Quarters > 3 > balance Sheet > total Assets
8000351
Quarters > 3 > balance Sheet > payables
1319143
Quarters > 3 > balance Sheet > short Term Debt
482455
Quarters > 3 > balance Sheet > long Term Debt
642280
Quarters > 3 > balance Sheet > total Liabilities
5979797
Quarters > 3 > balance Sheet > equity
2020553
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-85699.5
Quarters > 3 > cash Flow > depreciation
96570
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
663768
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.013797670693447514
Quarters > 3 > ratios > PB
0.4450668933207889
Quarters > 3 > ratios > ROE
4.498817897872513
Quarters > 3 > ratios > ROA
1.1362126486700395
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
47
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8698000
Annuals > 0 > income Statement > cost Of Revenue
6912000
Annuals > 0 > income Statement > gross Profit
1786000
Annuals > 0 > income Statement > operating Expenses
2931000
Annuals > 0 > income Statement > operating Income
-807000
Annuals > 0 > income Statement > interest Expense
4858
Annuals > 0 > income Statement > pretax Income
-352000
Annuals > 0 > income Statement > net Income
-256000
Annuals > 0 > income Statement > eps
-0.03800000059375001
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
6736842
Annuals > 0 > income Statement > income Tax Expense
-96000
Annuals > 0 > income Statement > EBITDA
-296000
Annuals > 0 > income Statement > operating Margin
-9.277994941365831
Annuals > 0 > income Statement > total Other Income Expense Net
455000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
1900000
Annuals > 0 > balance Sheet > short Term Investments
1046990
Annuals > 0 > balance Sheet > receivables
3156000
Annuals > 0 > balance Sheet > inventories
205000
Annuals > 0 > balance Sheet > total Current Assets
5262000
Annuals > 0 > balance Sheet > property Plant Equipment
112788
Annuals > 0 > balance Sheet > total Assets
5515000
Annuals > 0 > balance Sheet > payables
912942
Annuals > 0 > balance Sheet > short Term Debt
453403
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3759000
Annuals > 0 > balance Sheet > equity
1755000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-256000
Annuals > 0 > cash Flow > depreciation
57000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.03800000059375001
Annuals > 0 > ratios > PB
0.5258959282051282
Annuals > 0 > ratios > ROE
-14.586894586894585
Annuals > 0 > ratios > ROA
-4.641885766092475
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
12537433
Annuals > 1 > income Statement > cost Of Revenue
12544411
Annuals > 1 > income Statement > gross Profit
-6978
Annuals > 1 > income Statement > operating Expenses
5352510
Annuals > 1 > income Statement > operating Income
-183765
Annuals > 1 > income Statement > interest Expense
8370
Annuals > 1 > income Statement > pretax Income
-259081
Annuals > 1 > income Statement > net Income
-171399
Annuals > 1 > income Statement > eps
-0.025917929505239867
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
6613144
Annuals > 1 > income Statement > income Tax Expense
-87682
Annuals > 1 > income Statement > EBITDA
-52501
Annuals > 1 > income Statement > operating Margin
-1.4657306643233905
Annuals > 1 > income Statement > total Other Income Expense Net
-75316
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
1834484
Annuals > 1 > balance Sheet > short Term Investments
1044179
Annuals > 1 > balance Sheet > receivables
4302564
Annuals > 1 > balance Sheet > inventories
311449
Annuals > 1 > balance Sheet > total Current Assets
7684292
Annuals > 1 > balance Sheet > property Plant Equipment
143386
Annuals > 1 > balance Sheet > total Assets
8000351
Annuals > 1 > balance Sheet > payables
1319143
Annuals > 1 > balance Sheet > short Term Debt
482455
Annuals > 1 > balance Sheet > long Term Debt
642280
Annuals > 1 > balance Sheet > total Liabilities
5989254
Annuals > 1 > balance Sheet > equity
2011097
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-171399
Annuals > 1 > cash Flow > depreciation
198205
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
440296
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.025917929505239867
Annuals > 1 > ratios > PB
0.4505007605301982
Annuals > 1 > ratios > ROE
-8.522662009838411
Annuals > 1 > ratios > ROA
-2.1423935024850786
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
13166760
Annuals > 2 > income Statement > cost Of Revenue
13173115
Annuals > 2 > income Statement > gross Profit
-6355
Annuals > 2 > income Statement > operating Expenses
5520237
Annuals > 2 > income Statement > operating Income
-139125
Annuals > 2 > income Statement > interest Expense
11922
Annuals > 2 > income Statement > pretax Income
-143517
Annuals > 2 > income Statement > net Income
-3507
Annuals > 2 > income Statement > eps
-0.00052912032651869
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
6627982
Annuals > 2 > income Statement > income Tax Expense
-140010
Annuals > 2 > income Statement > EBITDA
69961
Annuals > 2 > income Statement > operating Margin
-1.0566380795275376
Annuals > 2 > income Statement > total Other Income Expense Net
-4391
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
2459704
Annuals > 2 > balance Sheet > short Term Investments
2047167
Annuals > 2 > balance Sheet > receivables
3486992
Annuals > 2 > balance Sheet > inventories
396927
Annuals > 2 > balance Sheet > total Current Assets
8555013
Annuals > 2 > balance Sheet > property Plant Equipment
276958
Annuals > 2 > balance Sheet > total Assets
9023099
Annuals > 2 > balance Sheet > payables
1605136
Annuals > 2 > balance Sheet > short Term Debt
547966
Annuals > 2 > balance Sheet > long Term Debt
1163587
Annuals > 2 > balance Sheet > total Liabilities
6822542
Annuals > 2 > balance Sheet > equity
2200557
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-1751.5
Annuals > 2 > cash Flow > depreciation
201556
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
403112
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-476766
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.00052912032651869
Annuals > 2 > ratios > PB
0.41263804300456663
Annuals > 2 > ratios > ROE
-0.1593687416413208
Annuals > 2 > ratios > ROA
-0.03886691257626675
Annuals > 2 > ratios > FCF
403112
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.030615884241833223
Annuals > 2 > health Score
18
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
11323959
Annuals > 3 > income Statement > cost Of Revenue
11280266
Annuals > 3 > income Statement > gross Profit
43693
Annuals > 3 > income Statement > operating Expenses
73247
Annuals > 3 > income Statement > operating Income
-29549
Annuals > 3 > income Statement > interest Expense
4885
Annuals > 3 > income Statement > pretax Income
-114319
Annuals > 3 > income Statement > net Income
15407
Annuals > 3 > income Statement > eps
0.0023277654509265585
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
6618794
Annuals > 3 > income Statement > income Tax Expense
-129726
Annuals > 3 > income Statement > EBITDA
96451
Annuals > 3 > income Statement > operating Margin
-0.26094230825102777
Annuals > 3 > income Statement > total Other Income Expense Net
-84770
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
2936470
Annuals > 3 > balance Sheet > short Term Investments
1844158
Annuals > 3 > balance Sheet > receivables
3666312
Annuals > 3 > balance Sheet > inventories
342581
Annuals > 3 > balance Sheet > total Current Assets
8971887
Annuals > 3 > balance Sheet > property Plant Equipment
415185
Annuals > 3 > balance Sheet > total Assets
9604488
Annuals > 3 > balance Sheet > payables
1771253
Annuals > 3 > balance Sheet > short Term Debt
320184
Annuals > 3 > balance Sheet > long Term Debt
1952743
Annuals > 3 > balance Sheet > total Liabilities
7418486
Annuals > 3 > balance Sheet > equity
2186002
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
15407
Annuals > 3 > cash Flow > depreciation
205889
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
411778
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
1917309
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
0.0023277654509265585
Annuals > 3 > ratios > PB
0.4148096744650737
Annuals > 3 > ratios > ROE
0.7048026488539352
Annuals > 3 > ratios > ROA
0.16041458951273613
Annuals > 3 > ratios > FCF
411778
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.03636343084604951
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.21297857539418502
Valuation > metrics > PB
2.6678528968893755
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-416.2604464034789
Profitability > metrics > ROA
-41.54670847598253
Profitability > metrics > Net Margin
-0.5487723168147239
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
9.656432026269469
Risk > metrics > Interest Coverage
-1008.925702811245
Risk > final Score
-4030
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.5937015878136047
Liquidity > metrics > Quick Ratio
3.3080659742707135
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
90
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-721
Prev Risks > 1
-588
Prev Risks > 2
58
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:08:54.084Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-29
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-07-30
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.02
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.02
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-04-24
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
0.02
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.02
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-10-18
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.02
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-04-29
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
0.07
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.07
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-10-08
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.06
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.06
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-04-19
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.06
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.06
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-18
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-03-31
Earnings History > 9 > report Date
2020-04-28
Earnings History > 9 > date
2020-03-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.04
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-11-15
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.08
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.08
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-03-31
Earnings History > 11 > report Date
2019-04-18
Earnings History > 11 > date
2019-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.09
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.09
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-20
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.08
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.08
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-04-13
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.08
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.08
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-10-05
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.1
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.1
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-03-31
Earnings History > 15 > report Date
2017-04-21
Earnings History > 15 > date
2017-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.12
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.12
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-09-30
Earnings History > 16 > report Date
2016-10-18
Earnings History > 16 > date
2016-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.2
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.2
Earnings History > 16 > surprise Percent
-
IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was incorporated in 2000 and is headquartered in Évry, France. IntegraGen SA operates as a subsidiary of OncoDNA SA.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Integragen
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.